Contact Information:

Media Contact

Edyta Zielinska
edyta.zielinska@jefferson.edu
215-955-5291

Twitter: JeffersonUniv

http://www.jefferson.edu/




Kredyty mieszkaniowe Kredyty mieszkaniowe

Sprawdź aktualny ranking najlepszych kredytów mieszkaniowych w Polsce - atrakcyjne kredytowanie nieruchomości.
PRESS-NEWS.org - Press Release Distribution
FREE PRESS RELEASES DISTRIBUTION
RSS - Press News Release
Add Press Release

Stress hormones could undermine breast cancer therapy

Stress hormones often given to patients to treat the side effects of therapy may cause a subset of breast cancers to become treatment-resistant


2015-06-22
(Press-News.org) (PHILADELPHIA) - Recently, researchers have discovered that the hormone progesterone, an ingredient in contraceptives and menopausal hormone replacement therapies, might stimulate the growth of breast cancer cells that are resistant to anti-estrogen therapy and chemotherapy. Now, new research published June 22nd in the journal Oncogene, a Nature publication, shows that additional hormones, including stress hormones that are frequently used to treat the side effects of common chemotherapy, could make these effective cancer drugs fail sooner in some women with breast cancer. But there may be ways to counteract the effect.

"The data we have collected suggests that hormones used in breast cancer treatment, which are also produced by the body in response to stress, could have a major impact on disease progression and outcomes in some patients," says Hallgeir Rui, M.D., Ph.D., a Professor of Cancer Biology, Pathology and Medical Oncology at Thomas Jefferson University. "However, these studies must be confirmed in clinical trials with patients before any new treatment recommendations can be made."

About 70-80 percent of all invasive breast cancers are driven by the hormone estrogen; they are often called estrogen receptor (ER) positive disease. This group of women can successfully keep the growth of their cancer in check with therapies that block estrogen receptors, or block the production of estrogen in the body, essentially starving the cancer. While some women can use hormone blockers such as tamoxifen or aromatase inhibitors to control their cancer for a decade or more, one of four will develop resistance.

Researchers believe that some of this resistance is caused by a small subpopulation of cancer cells within the tumor called CK5 cells which harbor the ability to resist estrogen-blocking therapy and chemotherapy. When these cells become more abundant, tumors become therapy-resistant. Dr. Rui estimates that 10-15 percent of patients with ER+ disease harbor CK5 cells.

Earlier work by the Rui laboratory and others had shown that progesterone spurs the growth of CK5 cells in breast cancer. But since most ER-positive breast cancers are diagnosed after menopause when progesterone production has stopped, this wasn't a major concern. Progesterone, however, belongs to a family of hormones called 3-ketosteroids that are often produced by the body in times of stress. Dr. Rui and colleagues decided to test whether other members of the 3-ketosteroid family, including glucocorticoids used to treat nausea and other breast-cancer-treatment related symptoms, might also expand the population of CK5 cells.

Dr. Rui and colleagues exposed breast cancer cell lines to four 3-ketosteroids. Two of the steroids, dexamethasone and aldosterone, boosted CK5-cell numbers by as much as four to seven times. The researchers also confirmed their results in human breast cancer grown in mice, showing increased growth of therapy-resistant tumors in mice treated with dexamethasone and aldosterone.

"Not only are these steroids sometimes used in cancer treatment, glucocorticoid hormones are also naturally produced by the body in response to stress," says first author Chelain Goodman, an M.D./Ph.D. student in Dr. Rui's lab. "Women with breast cancer experience greater levels of stress and studies have shown that this stress can negatively impact their treatment. Glucocorticoids are also widely prescribed for common diseases, including many chronic rheumatoid or autoimmune diseases which can co-occur with breast cancer. "This research helps pinpoint a new mechanism behind therapy-resistance in patients with this subtype of ER-positive breast cancer containing CK5 cells and suggests a way to counteract the effect," Ms. Goodman adds.

In order to counteract the effect of these stress hormones, Dr. Rui and colleagues turned to another hormone, called prolactin. Prolactin is best known for helping women produce milk after childbirth, but it also has the ability to maintain cell maturity. CK5 cells, on the hand, are cells that are less mature and more "primitive" or stem-cell like. Therefore, when Dr. Rui and colleagues added prolactin to the cells exposed to 3-ketosteroids, the expansion of CK5 cells was prevented. In other words, prolactin helped keep the breast cells mature, and made the environment unfavorable for growth of the immature-CK5 cells.

"Although prolactin appears to be an excellent candidate to counteract the effect of stress hormones on women with this subtype of breast cancer," says Dr. Rui, who leads the breast cancer program at the Sidney Kimmel Cancer Center at Jefferson, "the hormone can also drive other types of breast cancer, so we must proceed with caution. An alternative possibility supported by this research is inhibiting a protein called BCL6 that appears to be critical for steroid-induction of CK5 cells." Dr. Rui adds, "Perhaps the simplest solution would be to seek alternatives to steroids for controlling the side-effects of chemotherapy in patients with this tumor subtype." The group has already found two potential biomarkers in clinical samples that would help identify ER-positive tumors with CK5 cells and are looking into validating their findings in clinical trials.

INFORMATION:

The work was supported by grants from Susan G. Komen (KG091116), Ladies of Port Richmond, and NCI (CA185918; Support Grant 1P30CA56036), and in part, under a Commonwealth University Research Enhancement Program grant with the Pennsylvania Department of Health. The Department specifically disclaims responsibility for any analyses, interpretations or conclusions. The authors declare no conflict of interest.

For more information, contact Edyta Zielinska, 215-955-5291, edyta.zielinska@jefferson.edu.

Article reference: C.R. Goodman, et al., "Steroid-induction of therapy-resistant cytokeratin-5-positive cells in estrogen receptor-positive breast cancer through a BCL6-dependent mechanism," Oncogene, 2015. About Jefferson -- Health is all we do. Our newly formed organization, Jefferson, encompasses Jefferson Health and Thomas Jefferson University, representing our clinical and academic entities. Together, the people of Jefferson, 19,000 strong, provide the highest-quality, compassionate clinical care for patients, educate the health professionals of tomorrow, and discover new treatments and therapies that will define the future of health care.

Jefferson Health comprises five hospitals, 13 outpatient and urgent care centers, as well as physician practices and everywhere we deliver care throughout the city and suburbs across Philadelphia, Montgomery and Bucks Counties in Pa., and Camden County in New Jersey. Together, these facilities serve more than 78,000 inpatients, 238,000 emergency patients and 1.7 million outpatient visits annually. Thomas Jefferson University Hospital is the largest freestanding academic medical center in Philadelphia. Abington Hospital is the largest community teaching hospital in Montgomery or Bucks counties. Other hospitals include Jefferson Hospital for Neuroscience in Center City Philadelphia; Methodist Hospital in South Philadelphia; and Abington-Lansdale Hospital in Hatfield Township.

Thomas Jefferson University enrolls more than 3,900 future physicians, scientists, nurses and healthcare professionals in the Sidney Kimmel Medical College (SKMC); Jefferson Schools of Health Professions, Nursing, Pharmacy, Population Health; and the Graduate School of Biomedical Sciences, and is home of the National Cancer Institute (NCI)-designated Sidney Kimmel Cancer Center

For more information and a complete listing of Jefferson services and locations, visit http://www.jefferson.edu.


ELSE PRESS RELEASES FROM THIS DATE:

Cardiac device wearers should keep distance from smartphones

2015-06-22
Milan, Italy, June 22 -- Cardiac device wearers should keep a safe distance from smartphones to avoid unwanted painful shocks or pauses in function, reveals research presented today at EHRA EUROPACE -- CARDIOSTIM 2015 by Dr. Carsten Lennerz, first author and cardiology resident in the Clinic for Heart and Circulatory Diseases, German Heart Centre, Munich, Germany. The joint meeting of the European Heart Rhythm Association (EHRA) of the European Society of Cardiology (ESC) and Cardiostim is being held in Milan, Italy. The scientific programme is here: http://www.flipsnack.com/Escardio/ehra-europace-cardiostim-2015-advance-programme.html. Lennerz ...

Patients test drive pacemaker before choosing permanent implant

2015-06-22
Milan, Italy - 22 June 2015: Patients are test driving a pacemaker outside the skin before deciding whether to have a permanent implant, reveals novel research presented today at EHRA EUROPACE - CARDIOSTIM 2015 by Professor Michael Giudici, director of arrhythmia services in the Department of Internal Medicine, University of Iowa Hospitals and Clinics, Iowa City, US.1 "Wow, I didn't realise how terrible I felt. This is great. When can we schedule my pacemaker?" The joint meeting of the European Heart Rhythm Association (EHRA) of the European Society of Cardiology (ESC) ...

Study examines US trends in the use of penile prostheses to treat erectile dysfunction

2015-06-22
US researchers have published the first large population-based study of nationwide trends in erectile dysfunction and its surgical management from 2001 to 2010. Using data from Medicare beneficiaries, the investigators found that while the prevalence of erectile dysfunction increased by 165%, the use of penile prostheses decreased by 50%, from 4.6% in 2001 to 2.3% in 2010. Prostheses have been increasingly used in sicker patients with significant comorbidities, however. Age, ethnicity, and geography often influenced whether patients would undergo penile prosthetic placement. "The ...

Study finds decreased rates of high-grade cervical lesions in young women

2015-06-22
A new analysis indicates that rates of high-grade cervical lesions decreased in young U.S. women after vaccines were made available to protect against human papillomavirus (HPV), but the trend may be due in part to changes in cervical cancer screening recommendations. Published early online in Cancer, a peer-reviewed journal of the American Cancer Society, the study illustrates some of the challenges in monitoring a vaccine's impact during a time of concurrent changes in screening. More than half of high-grade cervical lesions, which are abnormal tissue changes that can ...

How to predict biphasic allergic reactions in children

2015-06-22
Ottawa, Ontario, June 22 -- Children are more likely to have a repeat, delayed anaphylactic reaction from the same allergic cause, depending on the severity of the initial reaction. The first pediatric study to look at the predictors for this phenomenon was published today in Annals of Allergy, Asthma & Immunology. Anaphylaxis is a severe, allergic reaction that is rapid in onset and can result in death. Some children are at risk of delayed ('biphasic') anaphylactic reactions. Delayed reactions occur when the initial symptoms of allergic reaction go away but then return ...

Silent flights: How owls could help make wind turbines and planes quieter

2015-06-22
An investigation into how owls fly and hunt in silence has enabled researchers to develop a prototype coating for wind turbine blades that could significantly reduce the amount of noise they make. Early tests of the material, which mimics the intricate structure of an owl's wing, have demonstrated that it could significantly reduce the amount of noise produced by wind turbines and other types of fan blades, such as those in computers or planes. Since wind turbines are heavily braked in order to minimise noise, the addition of this new surface would mean that they could ...

Children with good memories are better liars, research shows

2015-06-20
Children who benefit from a good memory are much better at covering up lies, researchers from the University of Sheffield have discovered. Experts found a link between verbal memory and covering up lies following a study which investigated the role of working memory in verbal deception amongst children. The study saw six to seven year old children presented with the opportunity to do something they were instructed not to -peek at the final answers on the back of a card during a trivia game. A hidden camera and correct answers to the question, which was based on ...

Moffitt researchers discover mechanism leading to BRAF inhibitor resistance in melanoma

2015-06-19
TAMPA, Fla. - The development of targeted therapies has significantly improved the survival of melanoma patients over the last decade; however, patients often relapse because many therapies do not kill all of the tumor cells, and the remaining cells adapt to treatment and become resistant. Moffitt Cancer Center researchers have discovered a novel mechanism that can lead melanoma cells to develop resistance to drugs that target the protein BRAF. Mutations in the gene BRAF are the most common mutation found in melanoma, with up to 50 percent of tumors testing positive for ...

Internists give Senate recommendations to improve care for patients with chronic diseases

2015-06-19
The American College of Physicians (ACP) letter in response to a May 22 Senate Finance Committee letter requesting recommendations and policies that will improve care for patients with chronic diseases. In a 19-page letter ACP President Wayne J. Riley, MD, MBA, MPH, MACP, to Finance Committee Chairman Orrin Hatch; Finance Committee Ranking Member Ron Wyden; Co-chairman of the Chronic Care Working Group Johnny Isakson; and Co-chairman of the Chronic Care Working Group Mark Warner, provides 18 detailed recommendations to: Expand the flexibility of Medicare Advantage ...

Latina women undergoing chemotherapy for breast cancer need more stress management tools

2015-06-19
TAMPA, Fla. - Cancer is the most common cause of death among Latinos. It is estimated that one out of every three Latina women will be diagnosed with cancer during her lifetime. Given the increasing Latino population in the United States, more emphasis has to be placed on educating this population about cancer. Moffitt Cancer Center researchers, along with collaborators at the University of South Florida, recently published a study about the attitudes and cultural perspectives of Latinas undergoing chemotherapy for breast cancer. The article also discusses their cancer ...

LAST 30 PRESS RELEASES:

How your brain decides blame and punishment -- and how it can be changed

Uniquely human brain region enables punishment decisions

Pinpointing punishment

Chapman University publishes research on attractiveness and mating

E-cigarettes: Special issue from Nicotine & Tobacco Research

Placental problems in early pregnancy associated with 5-fold increased risk of OB & fetal disorders

UT study: Invasive brood parasites a threat to native bird species

Criminals acquire guns through social connections

Restoring ocean health

Report: Cancer remains leading cause of death in US Hispanics

Twin study suggests genetic factors contribute to insomnia in adults

To be fragrant or not: Why do some male hairstreak butterflies lack scent organs?

International team discovers natural defense against HIV

Bolivian biodiversity observatory takes its first steps

Choice of college major influences lifetime earnings more than simply getting a degree

Dominant strain of drug-resistant MRSA decreases in hospitals, but persists in community

Synthetic biology needs robust safety mechanisms before real world application

US defense agencies increase investment in federal synthetic biology research

Robots help to map England's only deep-water Marine Conservation Zone

Mayo researchers identify protein -- may predict who will respond to PD-1 immunotherapy for melanoma

How much water do US fracking operations really use?

New approach to mammograms could improve reliability

The influence of citizen science grows despite some resistance

Unlocking secrets of how fossils form

What happens on the molecular level when smog gets into the lungs?

Using ultrasound to clean medical instruments

Platinum and iron oxide working together get the job done

Tiny silica particles could be used to repair damaged teeth, research shows

A quantum lab for everyone

No way? Charity's logo may influence perception of food in package

[Press-News.org] Stress hormones could undermine breast cancer therapy
Stress hormones often given to patients to treat the side effects of therapy may cause a subset of breast cancers to become treatment-resistant
Press-News.org is a service of DragonFly Company. All Rights Reserved.
Issuers of news releases are solely responsible for the accuracy of their content.